Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v2-EN
Language English English
Date Updated 2019-03-12 2019-03-11
Drug Identification Number 02381559 02381559
Brand name ARZERRA ARZERRA
Common or Proper name ARZERRA 100MG VIALS 5ML X 3 ARZERRA 100MG VIALS 5ML X 3
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients Ofatumumab Ofatumumab
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ml x3 5ml x3
ATC code L01XC L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-03-11 2019-03-11
Actual discontinuation date 2019-03-11 2019-03-11
Remaining supply date 2019-03-11 2019-03-11
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments